Trial intelligence / Profile preview

Colloid oncotic pressure during cardiopulmonary bypass priming in cardiac surgery

NL-OMON22437Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Dec 2020
Modality
Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Open-label trial of albumin (human) and gelatin in coronary arteriosclerosis and Cardiac valve disease (VHD) (3 arms), sponsored by Amsterdam University Medical Center. Planned start Dec 2020; status: not yet recruiting.

02

Drugs

albumin (human)gelatin
03

Conditions

coronary arteriosclerosisCardiac valve disease (VHD)

Beyond the preview

Go deeper on NL-OMON22437.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22437.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call